Progress in Medicinal Chemistry: Progress in Medicinal Chemistry, cartea 57
David R. Witty, Brian Coxen Limba Engleză Hardback – 10 apr 2018
- Provides extended, timely reviews of topics in medicinal chemistry
- Contains targets and technologies relevant to the discovery of tomorrow’s drugs
- Presents analyses of successful drug discovery programs
Preț: 870.61 lei
Preț vechi: 1287.64 lei
-32%
Puncte Express: 1306
Carte tipărită la comandă
Livrare economică 24 august-07 septembrie
Livrare prin curier în România Termenul estimat este afișat lângă disponibilitate.
Transport gratuit pentru acest produs Plată online sau ramburs, în funcție de opțiunile comenzii.
Retur gratuit în 14 zile Comandă securizată și suport în română.
Specificații
ISBN-13: 9780128152133
ISBN-10: 0128152133
Pagini: 366
Dimensiuni: 152 x 229 mm
Greutate: 0.66 kg
Editura: ELSEVIER SCIENCE
Seria Progress in Medicinal Chemistry
ISBN-10: 0128152133
Pagini: 366
Dimensiuni: 152 x 229 mm
Greutate: 0.66 kg
Editura: ELSEVIER SCIENCE
Seria Progress in Medicinal Chemistry
V-ar putea interesa
-
Chemical Sciences in Early Drug Discovery: Medicinal Chemistry 2.0Pierfausto Seneci-26%Preț: 389.97 lei530.31 lei -
-31%Preț: 350.66 lei505.79 lei -
Design of Hybrid Molecules for Drug DevelopmentMichael Decker-28%Preț: 951.98 lei1323.94 lei -
-15%Preț: 295.77 lei347.74 lei -
-31%Preț: 805.96 lei1171.16 lei -
-41%Preț: 971.14 lei1645.12 lei -
-27%Preț: 969.49 lei1327.23 lei -
UniversalBrian Cox-20%Preț: 73.67 lei92.27 lei -
Aromatic RingKen Tanaka-9%Preț: 1173.16 lei1289.19 lei -
TENNIS WITH GODBrian CoxPreț: 112.80 lei -
Organotrifluoroborate Preparation, Coupling and HydrolysisAlastair J. J. Lennox-15%Preț: 621.99 lei731.75 lei -
-8%Preț: 463.52 lei503.83 lei -
CYCLODEXTRIN CHEMISTRYJin Zheng-Yu-15%Preț: 619.81 lei729.19 lei
Public țintă
Everyone interested in the strategy and practice of the preclinical phases of the creation of new medicines. Those wishing to understand the drivers of drug design or expand their knowledge of therapeutic target classesCuprins
1. Discovery and Development of Calcimimetic and Calcilytic Compounds
Edward F. Nemeth, Bradford C. Van Wagenen and Manuel F. Balandrin
2. VMAT2 Inhibitors and the Path to Ingrezza (Valbenazine)
Nicole D. Harriott, John P. Williams, Evan B. Smith, Haig P. Bozigian and Dimitri E. Grigoriadis
3. Current Trends in Macrocyclic Drug Discovery and Beyond-Ro5
Sulejman Alihodzic, Mirjana Bukvic, Ivaylo J. Elenkov, Antun Hutinec, Sanja Koštrun, Dijana Pesic, Gordon Saxty, Linda Tomaškovic and Dinko Ziher
4. Recent Progress in the Discovery and Development of Small-Molecule Modulators of CFTR
Phil R. Kym, Xueqing Wang, Mathieu Pizzonero and Steven E. Van der Plas
5. Big Data in Drug Discovery
Nathan Brown, Jean Cambruzzi, Peter J. Cox, Mark Davies, James Dunbar, Dean Plumbley, Matthew A. Sellwood, Aaron Sim, Bryn I. Williams-Jones, Magdalena Zwierzyna and David W. Sheppard
Edward F. Nemeth, Bradford C. Van Wagenen and Manuel F. Balandrin
2. VMAT2 Inhibitors and the Path to Ingrezza (Valbenazine)
Nicole D. Harriott, John P. Williams, Evan B. Smith, Haig P. Bozigian and Dimitri E. Grigoriadis
3. Current Trends in Macrocyclic Drug Discovery and Beyond-Ro5
Sulejman Alihodzic, Mirjana Bukvic, Ivaylo J. Elenkov, Antun Hutinec, Sanja Koštrun, Dijana Pesic, Gordon Saxty, Linda Tomaškovic and Dinko Ziher
4. Recent Progress in the Discovery and Development of Small-Molecule Modulators of CFTR
Phil R. Kym, Xueqing Wang, Mathieu Pizzonero and Steven E. Van der Plas
5. Big Data in Drug Discovery
Nathan Brown, Jean Cambruzzi, Peter J. Cox, Mark Davies, James Dunbar, Dean Plumbley, Matthew A. Sellwood, Aaron Sim, Bryn I. Williams-Jones, Magdalena Zwierzyna and David W. Sheppard